The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Aug 2020 17:11

RNS Number : 5588V
Provexis PLC
07 August 2020
 

TR-1: Standard form for notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Provexis Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Stuart Lucas and family

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

6th August 2020

6. Date on which issuer notified (DD/MM/YYYY):

7th August 2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.02%

9.02%

2,059,321,507

Position of previous notification (if

applicable)

8.00%

8.00%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B0923P27

185,819,678

9.02%

SUBTOTAL 8. A

185,819,678

9.02%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

London, UK

Date of completion

7th August 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLSSAFMWESSESA
Date   Source Headline
20th Oct 20097:00 amRNSChange of Adviser
15th Oct 200910:46 amRNSResult of General Meeting
12th Oct 20097:00 amRNSProvexis Announces Update on Human Trial
7th Oct 20094:36 pmRNSHolding(s) in Company
2nd Oct 20091:09 pmRNSHolding(s) in Company
29th Sep 200910:00 amRNSPosting of Circular
28th Sep 20092:40 pmRNSHolding(s) in Company
25th Sep 20097:00 amRNSSubscription and Notice of General Meeting
23rd Sep 20099:54 amRNSShare Price Movement
17th Sep 20092:15 pmRNSDirectorate Change
10th Sep 20093:10 pmRNSResult of AGM
8th Sep 200912:33 pmRNSAdditional Listing
3rd Sep 20094:12 pmRNSAdditional Listing
3rd Sep 200912:37 pmRNSHolding(s) in Company
28th Aug 20098:53 amRNSRecent share price increase
26th Aug 20093:08 pmRNSDisposal of Provexis Holding
25th Aug 200910:32 amRNSHolding(s) in Company
25th Aug 200910:27 amRNSHolding(s) in Company
17th Aug 20099:25 amRNSAnnual Financial Report
11th Aug 20094:22 pmRNSHolding(s) in Company
11th Aug 20097:00 amRNSCommencement of Clinical Trial
10th Aug 20099:43 amRNSRecent share price movement
2nd Jul 20094:44 pmRNSHolding(s) in Company
9th Jun 20097:00 amRNSAudited Results Year ended 31 March 2009
28th May 20097:00 amRNSEuropean Health Claim Adoption for Fruitflow
4th Feb 20097:00 amRNSSirco Launch
3rd Feb 200912:39 pmRNSR&D Pipeline Update
3rd Feb 200911:32 amRNSFurther re Agreement
2nd Dec 20087:00 amRNSInterim Results
3rd Oct 200810:47 amRNSHolding(s) in Company
2nd Oct 20083:17 pmRNSDirector/PDMR Shareholding
2nd Oct 200811:08 amRNSResult of AGM
1st Oct 20087:00 amRNSDirectorate Change
16th Sep 20083:22 pmRNSAdditional Listing
11th Sep 20089:49 amRNSAnnual Report and Accounts
2nd Sep 200811:44 amRNSHolding(s) in Company
1st Sep 20085:50 pmRNSGrant of options
1st Sep 200812:57 pmRNSDirectorate Change
29th Aug 20089:32 amRNSHolding(s) in Company
26th Aug 200810:41 amRNSResult of Meeting
21st Aug 20087:00 amRNSJoint Venture Project
4th Aug 20087:00 amRNSProvexis Fundraising
1st Aug 20084:32 pmRNSFinal Results
1st Aug 20084:30 pmRNSPlacing and Share Reorganisat
9th Jun 20084:52 pmRNSResponse to Share Price Movem
27th Mar 200810:07 amRNSHolding(s) in Company
20th Mar 20083:08 pmRNSHolding(s) in Company
3rd Mar 20089:51 amRNSHolding(s) in Company
25th Jan 200810:39 amRNSHolding(s) in Company
6th Dec 20072:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.